Fertilizers & Agrochemicals
Valuation | |
|---|---|
| Market Cap | 21.89 kCr |
| Price/Earnings (Trailing) | 28.36 |
| Price/Sales (Trailing) | 3.98 |
| EV/EBITDA | 21 |
| Price/Free Cashflow | 97.29 |
| MarketCap/EBT | 23.69 |
| Enterprise Value | 21.89 kCr |
Fundamentals | |
|---|---|
| Revenue (TTM) | 5.5 kCr |
| Rev. Growth (Yr) | 16.6% |
| Earnings (TTM) | 772.2 Cr |
| Earnings Growth (Yr) | 9.6% |
Profitability | |
|---|---|
| Operating Margin | 17% |
| EBT Margin | 17% |
| Return on Equity | 27.09% |
| Return on Assets | 14.72% |
| Free Cashflow Yield | 1.03% |
Growth & Returns | |
|---|---|
| Price Change 1W | -3.2% |
| Price Change 1M | -3.6% |
| Price Change 6M | 4.2% |
| Price Change 1Y | -26.5% |
| 3Y Cumulative Return | 1.6% |
| 5Y Cumulative Return | -1.9% |
| 7Y Cumulative Return | 3.2% |
| 10Y Cumulative Return | 3.6% |
Cash Flow & Liquidity | |
|---|---|
| Cash Flow from Investing (TTM) | 85.6 Cr |
| Cash Flow from Operations (TTM) | 262 Cr |
| Cash Flow from Financing (TTM) | -619.4 Cr |
| Cash & Equivalents | 885.5 Cr |
| Free Cash Flow (TTM) | 236.2 Cr |
| Free Cash Flow/Share (TTM) | 52.56 |
Balance Sheet | |
|---|---|
| Total Assets | 5.25 kCr |
| Total Liabilities | 2.4 kCr |
| Shareholder Equity | 2.85 kCr |
| Current Assets | 4.47 kCr |
| Current Liabilities | 2.22 kCr |
| Net PPE | 426.9 Cr |
| Inventory | 2.36 kCr |
| Goodwill | 0.00 |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.00 |
| Debt/Equity | 0.00 |
| Interest Coverage | 46.4 |
| Interest/Cashflow Ops | 14.44 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 125 |
| Dividend Yield | 2.57% |
| Shares Dilution (1Y) | 0.00% |
| Shares Dilution (3Y) | 0.00% |
Summary of Bayer CropScience's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
Last updated:
Last updated:
Understand Bayer CropScience ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| Bayer Vapi Private Limited | 17.89% |
| Bayer Investments India Private Limited | 15.04% |
| Bayer SAS | 14.73% |
| Bayer CropScience AG | 11.91% |
| Bayer AG | 8.43% |
| Monsanto Company | 3.44% |
| Quant Mutual Fund - Quant Small Cap Fund | 2.4% |
| Aditya Birla Sun Life Trustee Private Limited A/C Aditya Birla Sun Life Frontline Equity Fund | 1.7% |
| Indian Syntans Investments Private Limited | 1.04% |
Distribution across major stakeholders
Distribution across major institutional holders
Detailed comparison of Bayer CropScience against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| UPL | UPL | 61.69 kCr | 47.32 kCr | +8.40% | +32.00% | 54.04 | 1.3 | - | - |
| PIIND | PI Industries | 55.91 kCr | 8.17 kCr | +1.90% | -17.90% | 34.69 | 6.85 | - | - |
| SHARDACROP | Sharda Cropchem | 7.37 kCr | 4.76 kCr | -4.00% | +8.10% | 16.3 | 1.55 | - | - |
| DHANUKA | Dhanuka Agritech | 6.34 kCr | 2.07 kCr | -14.60% | -17.10% | 21.45 | 3.06 | - | - |
| RALLIS | Rallis India | 5.11 kCr | 2.81 kCr | -15.80% | -22.60% | 29.15 | 1.82 | - | - |
Comprehensive comparison against sector averages
BAYERCROP metrics compared to Fertilizers
| Category | BAYERCROP | Fertilizers |
|---|---|---|
| PE | 28.43 | 37.50 |
| PS | 3.99 | 2.36 |
| Growth | 8.1 % | 6.6 % |
Bayer CropScience is a prominent company in the Pesticides & Agrochemicals sector, with the stock ticker BAYERCROP.
With a market capitalization of Rs. 23,100.2 Crores, the company operates in the manufacture, sale, and distribution of a range of products including insecticides, fungicides, herbicides, and corn seeds, with a presence in India, Germany, Bangladesh, and other international markets.
In addition to its agrochemical business, Bayer CropScience is involved in healthcare, providing medicines primarily targeting therapeutic areas such as cardiology, gynecology, diabetes, oncology, and ophthalmology. The company also offers imaging devices like computed tomography, X-Ray, and magnetic resonance imaging, along with consumer health products aimed at treating minor illnesses.
Bayer CropScience has diversified its portfolio by selling and distributing hybrid seeds, including corn and paddy. To further enhance its offerings, the company provides digital farming solutions, including applications such as FarmRise, drones for spray services, and various technologies like remote sensing, IoT sensors, GPS, artificial intelligence, and data analytics, which aid in monitoring and managing crop growth, soil quality, and weather patterns.
Founded in 1863 and based in Thane, India, Bayer CropScience has shown marked performance, with a trailing 12 months revenue of Rs. 5,082.6 Crores and a profit of Rs. 666.2 Crores over the past four quarters. It distributes dividends to its investors, with a yield of 2.43% per annum, having returned Rs. 125 dividend per share in the last 12 months. However, the company experienced a one-year revenue growth of -3.8%.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
BAYERCROP vs Fertilizers (2021 - 2025)